Researchers continue to excited about Retatrutide , a novel dual compound showing promising outcomes in early trials for size reduction . It acts by targeting both hormones : GLP-1 and GIP, that , when https://lilliigui021088.diowebhost.com/95953562/a-new-possibility-for-size-loss